Arizona State Retirement System’s Rubius Therapeutics, Inc RUBY Stock Holding History

Arizona State Retirement System’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,931	Closed	-$60K	–	2324
2022 Q1	$60K	Buy	10,931 +58	+0.5%	+$368	﹤0.01%	2206
2021 Q4	$105K	Sell	10,873 -75	-0.7%	-$1.04K	﹤0.01%	2212
2021 Q3	$196K	Buy	10,948 +1,018	+10%	+$22.1K	﹤0.01%	2084
2021 Q2	$242K	Buy	9,930 +507	+5%	+$12.7K	﹤0.01%	2004
2021 Q1	$250K	Buy	+9,423	New	+$138K	﹤0.01%	1925

Other funds holding RUBY

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AFM

Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arizona State Retirement System's RUBY Position: Q2 2022 in Review

Arizona State Retirement System sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 10,931 shares — an estimated $60K sold.

Arizona State Retirement System first reported a position in RUBY in Q1 2021 and held it in 5 quarters. The position peaked at $250K in Q1 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

Arizona State Retirement System reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
Arizona State Retirement System sold 10,931 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $60K.
Arizona State Retirement System first reported a position in Rubius Therapeutics, Inc in Q1 2021 and held it in 5 quarters.
Arizona State Retirement System's Rubius Therapeutics, Inc position peaked at $250K in Q1 2021.
72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Arizona State Retirement System's 13F filing for Q2 2022, filed 28 Jul 2022.